Die Chemische und Pharmazeutische Industrie ist nicht zuletzt wegen ihrer starken Export- und Forschungsorientierung einer der Wachstumsträger der deutschen Volkswirtschaft. Prinzipiell gilt dies auch für Ostdeutschland. Wie in diesem Beitrag gezeigt wird, sind insbesondere die dortigen...

This primer aims to provide IMF macroeconomists with the essential information they need in situations where they must address issues concerning health sector policy and when they have significant macroeconomic implications. Such issues can also affect equity and growth and are fundamental to...

This paper studies oligopolistic competition in off-patent pharmaceutical markets using a vertical product differentiation model. This model can explain the observation that countries with stronger regulations have smaller generic market shares. It can also explain the differences in observed...

In this paper, the impact of increased information on brand name and generic pharmaceutical prices is analyzed both theoretically and empirically. The theoretical results show that an increase in information is likely to reduce the price of brand name pharmaceuticals, while the results regarding...

В статье проанализирован сектор производства отечественных лекарственных средств, его тенденции и проблемы развития. Определены основные особенности...

В статье оценивается конкурентоспособность российской экономики в целом и на уровне фармацевтической отрасли по основополагающим позициям, выделенным в...

Статья посвящена современному здравоохранению России и его трансформации в новую систему, позволяющую в условиях формирования рыночных отношений сделать...

Outsourcing is a useful tool for improving partnership between private and public companies. The budgetary constraints recently imposed by the Italian government on health industry are enhancing the urgency to outsource in order to cope the cost containment. Our study deals with the relationship...

Firms across sectors and regions are highly skewed in their ability to engage with innovation and even more skewed in their ability to translate investments in innovation into higher growth. Recent attention has been placed on the importance of ‘high-growth firms’ (HGF) for innovation...